Skip to the page

Data / Form D filings / Aletheia BioTherapeutics, LLC

Aletheia BioTherapeutics, LLC: Form D filings

Aletheia BioTherapeutics, LLC, a health care company in New York, NY, filed 4 Form D notices with the SEC between 2019 and 2024. The latest, on December 2, 2024, reports $5.1 million sold of a $7.4 million offering to 19 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
17 STATE STREET, 3RD FLOOR, SUITE 350, New York, NY, 10004
Phone
(212) 509-7708
Industry
Other Health Care
Entity type
Limited Liability Company
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1765522

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 2, 2024New notice$7,420,000$5,136,421$2,283,57919Oct 2, 2024sec.gov
Nov 27, 2024New notice$7,420,000$5,136,421$2,283,57919Oct 2, 2024sec.gov
Aug 16, 2023New notice$6,000,001$5,996,991$3,01018Jul 11, 2023sec.gov
Jan 24, 2019New notice$1,600,000$1,600,0003Nov 16, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Thomas BartonDirector
Michael MuhonenDirector
Laurie PlatekExecutive Officer, Director
Chrystyna BedrijExecutive Officer

Other health care companies in New York that filed recently

Every Form D from the week of Dec 2, 2024 · All recent filings in New York · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Aletheia BioTherapeutics, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.